🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Cancer Research ── Pancreatic ── 2026-09-30

A histology slide under soft light with two diverging beams, symbolizing AI-guided treatment choice in pancreatic cancer research.
What this means, as an image (AI-generated, GPT Image): AI analysis of pancreatic cancer pathology slides could help doctors choose which chemotherapy benefits each patient more.Download image (PNG, 2000×800)
Diagram of two pancreatic cancer studies. Resected PDAC histology enters a three-step line: current practice and hypothesis, regimen-specific model building, and external validation in a randomized trial, ending in a treatment-choice clue. Adjuvant chemotherapy is mainly guided by general condition; the models estimate relative benefit of GEM versus mFOLFIRINOX. A separate route, HPSurv, predicts overall survival from whole-slide images.
Image abstract — the whole article on one page (click to enlarge)
2 Pancreatic papers. Lead: Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

Journals covered and how papers are chosen: see the index

Pancreatic cancer: treatment, trials and AI

← Back to this issue